Sir Richard Branson

The deal values 23andMe at approximately $3.5 billion through the combination of stock and cash financing.

23andMe heads to public markets through SPAC merger with VG Acquisition Corp.

By Mallory Hackett 11:56 am February 4, 2021

Consumer genomics platform 23andMe is on its way to becoming a publicly-traded company through its merger with VG Acquisition Corp., a special purpose acquisition company sponsored by Virgin Group. The two companies announced today they have entered into a definitive merger agreement that is expected to close in the second quarter of this year. Once completed, the combined companies’ stock will...

Doctor on Demand raises $50M for video visits, 23andMe CEO invests

By Aditi Pai 06:19 am June 17, 2015

San Francisco-based video visits company Doctor On Demand raised $50 million in a round led by Tenaya Capital with participation from new investors Qualcomm Ventures, Dignity Health, and 23andMe CEO Anne Wojcicki. Existing investors, Venrock, Shasta Ventures, and Sir Richard Branson also contributed. Doctor On Demand has raised more than $74 million in funding to date. Doctor On Demand offers its...